Clinical Laserthermia Systems: Funding, Investors & Team (Sep 2026)
Clinical Laserthermia Systems AB (publ) develops and sells the TRANBERG® Thermal Therapy Systems, including ThermoguideTM Workstation and sterile disposables, for minimally invasive laser ablation of soft tissue, cancer tumors and drug-resistant epilepsy, according to regulatory approvals in the EU and the US. CLS aims at expanding the current approvals to also include treatment with imILT®, the Company's interstitial laser thermotherapy for immunostimulatory ablation with potential abscopal treatment effect. CLS is headquartered in Lund and has subsidiaries in Germany, the US and Singapore. CLS is listed on the Nasdaq First North Growth Market under the symbol CLS B.
Clinical Laserthermia Systems has raised $2.0M across 1 funding round on record, the most recent an undisclosed round of $2.0M announced in Nov 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Clinical Laserthermia Systems Company Profile and Key Stats
Latest funding round on record: Nov 2024.
Clinical Laserthermia Systems Funding Rounds
Clinical Laserthermia Systems Founders and Leadership Team
No contact details are on record for this team yet.
Clinical Laserthermia Systems Funding Compared to Other Biotechnology Startups
Clinical Laserthermia Systems' latest round of $2.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Clinical Laserthermia Systems in Biotechnology and Lund
Companies Similar to Clinical Laserthermia Systems
Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and…
Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic…
Emulsi Biotech is a biotechnology company that develops lipid technology to deliver biologic drugs orally.
Our vision is to develop and bring to the market safe and effective treatments for women specific diseases…
OncoZenge is a Swedish pharmaceutical company. It develops better products for the supportive care of cancer…
Elicera Therapeutics is a clinical stage immuno-oncology company developing cell and gene therapies for…
Alligator Bioscience is an innovative research based biotech company focused on developing novel drugs for…
Moleculent is dedicated to creating tech-based products that utilize fresh knowledge about the molecular…
Bio-Works was established in 2006 and specializes in creating, producing, and distributing cutting-edge…
Verigraft AB is a biotech company that creates personalized tissue-engineered transplants for use in…
Lipum aims to eliminate or alleviate painful symptoms for millions of patients suffering from chronic…
ArgusEye is a biotech firm that offers sensor solutions for instant identification of biological systems and…
Clinical Laserthermia Systems Funding FAQs
What does Clinical Laserthermia Systems do?
Clinical Laserthermia Systems AB (publ) develops and sells the TRANBERG® Thermal Therapy Systems, including ThermoguideTM Workstation and sterile disposables, for minimally invasive laser ablation of soft tissue, cancer tumors and drug-resistant epilepsy, according to regulatory approvals in the EU and the US. CLS aims at expanding the current approvals to also include treatment with imILT®, the Company's interstitial laser thermotherapy for immunostimulatory ablation with potential abscopal treatment effect. CLS is headquartered in Lund and has subsidiaries in Germany, the US and Singapore. CLS is listed on the Nasdaq First North Growth Market under the symbol CLS B.
How much funding has Clinical Laserthermia Systems raised?
Clinical Laserthermia Systems has raised $2.0M across 1 round on record. The most recent is an undisclosed round of $2.0M announced in Nov 2024.
When did Clinical Laserthermia Systems last raise funding?
Clinical Laserthermia Systems' most recent funding round on record is an undisclosed round of $2.0M, announced in Nov 2024.
Who founded Clinical Laserthermia Systems?
FundedIQ lists Par H Henriksson (Founder) at Clinical Laserthermia Systems.
Where is Clinical Laserthermia Systems headquartered?
Clinical Laserthermia Systems is based in Lund, Skane Lan, Sweden.
How many employees does Clinical Laserthermia Systems have?
Clinical Laserthermia Systems is in the 11-50 employee band.
How does Clinical Laserthermia Systems' funding compare to other Biotechnology startups?
Clinical Laserthermia Systems' latest round of $2.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Clinical Laserthermia Systems Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Clinical Laserthermia Systems is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.